Abstract:What's New? While survival rates for childhood acute lymphoblastic leukemia (ALL) are high, many affected children and adolescents are impacted by treatment‐related adverse effects. In this study, data from different Swedish nationwide registers were combined to more closely examine the impacts of ALL treatment on educational outcomes. Analyses show that Swedish children diagnosed with ALL between 1990 and 2010 had relatively typical educational outcomes, compared with healthy controls. However, odds for delayed graduation, worse scores in physical education, and failing English were elevated among some children treated for ALL. The findings highlight the importance of evaluating especially high‐risk children diagnosed with ALL in order to identify those who may require educational support and for designing targeted interventions. Acute lymphoblastic leukemia (ALL) constitutes approximately 25% of pediatric cancers, and with contemporary protocols, the 5‐year survival rate is over 90%. Despite improved survival, neurocognitive impairments from treatment raise concerns. This registry study aimed to explore the impact of ALL treatment on educational outcomes from school year nine in Swedish children. A population‐based cohort of 503 children diagnosed with ALL from 1990 to 2010 was identified from the Swedish Childhood Cancer Registry and matched with five controls each. Assessed variables were delayed graduation, high school eligibility, total merit value, school grades in Swedish, English, mathematics, and physical education, and results in national tests. Analyses were performed between cases and controls and by sex, age at diagnosis, and risk group. Our results showed that, compared to controls, cases had higher odds for delayed graduation, poorer results in physical education, and higher rates of absence in national tests in English and mathematics. Children in the standard‐risk group (treated with first‐line chemotherapy only) exhibited similar results to matched controls whereas children in the high‐risk group (treated with cranial irradiation, hematological stem cell transplantation, or/and for ALL relapse and thus likely received also radiotherapy) had lower total merit value compared to controls. We conclude that Swedish children diagnosed with ALL between the years 1990–2010 mainly exhibited comparable educational outcomes to controls, although children in the high‐risk group had lower results. These findings highlight the importance of evaluating especially children with high‐risk ALL in order to identify those requiring educational support and for designing targeted interventions.

Symptomatic osteonecrosis in children treated for Hodgkin lymphoma: A population-based study in Sweden, Finland, and Denmark

Radiological follow-up of osteonecrosis lesions in children and adolescents with Hodgkin lymphoma

Juvenile-onset Multifocal Osteonecrosis in Systemic Lupus Erythematosus: A Case Report.

Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series

Asian population may have a lower incidence of hip osteonecrosis in childhood acute lymphoblastic leukemia

Clinic study progress of Hodgkin lymphoma in children and adolescents

Genetic polymorphism of vitamin D receptors and plasminogen activator inhibitor-1 and osteonecrosis risk in childhood acute lymphoblastic leukemia

Clinical Presentation and Outcome of Pediatric Patients with Hemophagocytic Lymphohistiocytosis in China: A Retrospective Multicenter Study

Educational outcomes school year nine in children treated for acute lymphoblastic leukemia: A nationwide registry‐based study from Sweden

Clinical Features and Factors Associated with Osteonecrosis in Childhood-Onset Systemic Lupus Erythematosus

Mitigating immortal-time bias: exploring osteonecrosis and survival in pediatric ALL - AALL0232 trial insights

Multiple Subsequent Neoplasms in the Childhood Cancer Survivor Study (ccss) Cohort

Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children

Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study

Outcome and prognostic factors of pediatric patients with Hodgkin lymphoma: a single-center experience

Late-onset pulmonary complications following allogeneic hematopoietic cell transplantation in pediatric patients: a prospective multicenter study

Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia

The association of an elevated Th/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients

Glucocorticoid‐induced osteonecrosis in systemic lupus erythematosus patients

Late outcomes in children and adolescents with non-Hodgkin lymphoma: A single-center experience

Toward Inclusive Oncology: Challenges in the Therapy of Pediatric Non-B Non-Hodgkin Lymphomas